FOXO1 and diabetic kidney disease: Notably, others have previously shown that FoxO1 overexpression is beneficial in DKD, at least in part by the protection of podocytes against epithelial–mesenchymal transition [47]; based on our findings it would be interesting to determine the role of IGFBP-1 in this pathway.